Cambridge Investment Research Advisors’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.48M | Buy |
34,463
+3,627
| +12% | +$341K | 0.01% | 1507 |
|
|
2026
Q1 | $3.65M | Sell |
30,836
-694
| -2% | -$85.8K | 0.01% | 1161 |
|
|
2025
Q4 | $3.97M | Sell |
31,530
-7,853
| -20% | -$1.02M | 0.01% | 1054 |
|
|
2025
Q3 | $5.76M | Sell |
39,383
-5,187
| -12% | -$784K | 0.02% | 832 |
|
|
2025
Q2 | $6.95M | Sell |
44,570
-1,416
| -3% | -$225K | 0.02% | 695 |
|
|
2025
Q1 | $7.57M | Sell |
45,986
-9,433
| -17% | -$1.57M | 0.03% | 607 |
|
|
2024
Q4 | $9.03M | Sell |
55,419
-6,381
| -10% | -$1.14M | 0.03% | 527 |
|
|
2024
Q3 | $12.1M | Buy |
61,800
+1,040
| +2% | +$192K | 0.04% | 437 |
|
|
2024
Q2 | $10.5M | Sell |
60,760
-6,269
| -9% | -$1.04M | 0.04% | 442 |
|
|
2024
Q1 | $11.3M | Buy |
67,029
+7,217
| +12% | +$1.35M | 0.04% | 412 |
|
|
2023
Q4 | $11.8M | Sell |
59,812
-1,897
| -3% | -$336K | 0.05% | 346 |
|
|
2023
Q3 | $10.7M | Sell |
61,709
-1,525
| -2% | -$277K | 0.05% | 357 |
|
|
2023
Q2 | $10.9M | Buy |
63,234
+265
| +0.4% | +$45.8K | 0.05% | 361 |
|
|
2023
Q1 | $10.5M | Sell |
62,969
-6,814
| -10% | -$1.12M | 0.05% | 359 |
|
|
2022
Q4 | $10.2M | Buy |
69,783
+9,040
| +15% | +$1.34M | 0.05% | 360 |
|
|
2022
Q3 | $9.01M | Buy |
60,743
+1,656
| +3% | +$277K | 0.05% | 350 |
|
|
2022
Q2 | $10.2M | Buy |
59,087
+4,504
| +8% | +$779K | 0.05% | 327 |
|
|
2022
Q1 | $10.3M | Sell |
54,583
-4,536
| -8% | -$897K | 0.05% | 364 |
|
|
2021
Q4 | $14.4M | Buy |
59,119
+3,280
| +6% | +$718K | 0.06% | 283 |
|
|
2021
Q3 | $10.8M | Sell |
55,839
-1,289
| -2% | -$260K | 0.05% | 334 |
|
|
2021
Q2 | $10.6M | Buy |
57,128
+4,074
| +8% | +$708K | 0.05% | 348 |
|
|
2021
Q1 | $8.36M | Buy |
53,054
+6,560
| +14% | +$1.04M | 0.05% | 385 |
|
|
2020
Q4 | $7.7M | Sell |
46,494
-3,912
| -8% | -$636K | 0.05% | 380 |
|
|
2020
Q3 | $8.34M | Buy |
50,406
+4,281
| +9% | +$658K | 0.06% | 315 |
|
|
2020
Q2 | $6.32M | Buy |
46,125
+14,378
| +45% | +$1.88M | 0.05% | 369 |
|
|
2020
Q1 | $3.74M | Buy |
31,747
+2,237
| +8% | +$295K | 0.04% | 456 |
|
|
2019
Q4 | $3.91M | Buy |
29,510
+2,127
| +8% | +$264K | 0.03% | 555 |
|
|
2019
Q3 | $3.41M | Buy |
27,383
+1,434
| +6% | +$173K | 0.03% | 555 |
|
|
2019
Q2 | $2.94M | Buy |
25,949
+1,558
| +6% | +$163K | 0.03% | 580 |
|
|
2019
Q1 | $2.46M | Buy |
24,391
+2,343
| +11% | +$213K | 0.02% | 638 |
|
|
2018
Q4 | $1.89M | Buy |
22,048
+2,719
| +14% | +$245K | 0.02% | 656 |
|
|
2018
Q3 | $1.77M | Buy |
19,329
+164
| +0.9% | +$14.5K | 0.02% | 735 |
|
|
2018
Q2 | $1.63M | Buy |
19,165
+254
| +1% | +$21.4K | 0.02% | 729 |
|
|
2018
Q1 | $1.58M | Buy |
18,911
+1,030
| +6% | +$81.1K | 0.02% | 718 |
|
|
2017
Q4 | $1.29M | Buy |
17,881
+3,904
| +28% | +$268K | 0.02% | 789 |
|
|
2017
Q3 | $891K | Buy |
13,977
+1,692
| +14% | +$106K | 0.01% | 897 |
|
|
2017
Q2 | $766K | Sell |
12,285
-559
| -4% | -$33K | 0.01% | 948 |
|
|
2017
Q1 | $685K | Buy |
12,844
+532
| +4% | +$28.7K | 0.01% | 917 |
|
|
2016
Q4 | $659K | Buy |
12,312
+176
| +1% | +$8.95K | 0.01% | 880 |
|
|
2016
Q3 | $631K | Buy |
12,136
+295
| +2% | +$14.9K | 0.01% | 916 |
|
|
2016
Q2 | $562K | Buy |
11,841
+2,025
| +21% | +$95.7K | 0.01% | 884 |
|
|
2016
Q1 | $435K | Sell |
9,816
-1,070
| -10% | -$45.4K | 0.01% | 969 |
|
|
2015
Q4 | $522K | Buy |
10,886
+835
| +8% | +$37.7K | 0.01% | 834 |
|
|
2015
Q3 | $414K | Buy |
10,051
+435
| +5% | +$20.2K | 0.01% | 861 |
|
|
2015
Q2 | $464K | Buy |
9,616
+3,945
| +70% | +$188K | 0.01% | 849 |
|
|
2015
Q1 | $263K | Buy |
+5,671
| New | +$256K | 0.01% | 1114 |
|
Other funds holding ZTS
Cambridge Investment Research Advisors's ZTS Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Zoetis (ZTS) stake by 12% in Q2 2026, buying an estimated $341K and bringing the position to 34,463 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #1507.
Cambridge Investment Research Advisors first reported a position in ZTS in Q1 2015 and has held it in 46 quarters since. The position peaked at $14.4M in Q4 2021. 1,423 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Cambridge Investment Research Advisors held 34,463 shares of Zoetis worth $2.48M as of Q2 2026.
- Cambridge Investment Research Advisors bought 3,627 Zoetis shares in Q2 2026, an estimated $341K.
- Zoetis made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1507 holding.
- Cambridge Investment Research Advisors first reported a position in Zoetis in Q1 2015 and has held it in 46 quarters since.
- Cambridge Investment Research Advisors's Zoetis position peaked at $14.4M in Q4 2021.
- 1,423 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.